Medistim ASA/Nkr MEDI
07:00
08:50
10:40
12:30
14:20
1D1W1MYTD1Y5YMAX
About Medistim ASA
Medistim ASA is a Norwegian company specializing in the development and commercialization of medical devices used in cardiac, vascular, and transplant surgery. Its core business focuses on intraoperative blood flow measurement technology, notably through its proprietary products like the VeriQ and MiraQ systems. These systems are crucial for ensuring optimal blood flow during surgeries, thus helping to improve clinical outcomes. Founded in 1984, Medistim is headquartered in Oslo, Norway, and operates with a global network, distributing its products worldwide. The company's strategic strengths lie in its specialized focus on niche surgical applications and its continued innovation in medical technology.
Ticker
Nkr MEDI
Sector
Primary listing
XOSL
Employees
159
Headquarters
Oslo, Norway
Website
Medistim ASA Metrics
BasicAdvanced
kr 4.2bn
26.94
kr 8.54
1.01
kr 8.00
3.48%
Price and volume
Market cap
kr 4.2bn
Beta
1.01
52-week high
kr 292.00
52-week low
kr 186.50
Average daily volume
31k
Dividend rate
kr 8.00
Financial strength
Current ratio
3.796
Quick ratio
2.559
Long term debt to equity
6.827
Total debt to equity
6.827
Dividend payout ratio (TTM)
70.13%
Interest coverage (TTM)
18.82%
Profitability
EBITDA (TTM)
201.117
Gross margin (TTM)
80.71%
Net profit margin (TTM)
21.68%
Operating margin (TTM)
26.96%
Effective tax rate (TTM)
22.60%
Revenue per employee (TTM)
kr 4,530,000
Management effectiveness
Return on assets (TTM)
18.68%
Return on equity (TTM)
32.08%
Valuation
Price to earnings (TTM)
26.937
Price to revenue (TTM)
5.84
Price to book
8.27
Price to tangible book (TTM)
10.13
Price to free cash flow (TTM)
29.509
Free cash flow yield (TTM)
3.39%
Free cash flow per share (TTM)
7.794
Dividend yield (TTM)
3.48%
Forward dividend yield
3.48%
Growth
Revenue change (TTM)
17.94%
Earnings per share change (TTM)
27.28%
3-year revenue growth (CAGR)
12.96%
10-year revenue growth (CAGR)
10.83%
3-year earnings per share growth (CAGR)
10.43%
10-year earnings per share growth (CAGR)
13.82%
3-year dividend per share growth (CAGR)
21.14%
10-year dividend per share growth (CAGR)
17.10%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs